These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6227748)

  • 1. Resolution of etodolac and antiinflammatory and prostaglandin synthetase inhibiting properties of the enantiomers.
    Demerson CA; Humber LG; Abraham NA; Schilling G; Martel RR; Pace-Asciak C
    J Med Chem; 1983 Dec; 26(12):1778-80. PubMed ID: 6227748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etodolac (1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid): a potent antiinflammatory drug. Conformation and absolute configuration of its active enantiomer.
    Humber LG; Demerson CA; Swaminathan P; Bird PH
    J Med Chem; 1986 May; 29(5):871-4. PubMed ID: 2939246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of 4,6-diethyl-1,3,4,5-tetrahydropyrano[4,3-b]indole-4-acetic acid, an isomer of etodolac.
    Hughes P; DeVirgilio J; Humber LG; Chau T; Weichman B; Neuman G
    J Med Chem; 1989 Sep; 32(9):2134-7. PubMed ID: 2527995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etodolac, a novel antiinflammatory agent. The syntheses and biological evaluation of its metabolites.
    Humber LG; Ferdinandi E; Demerson CA; Ahmed S; Shah U; Mobilio D; Sabatucci J; De Lange B; Labbadia F; Hughes P
    J Med Chem; 1988 Sep; 31(9):1712-9. PubMed ID: 2970548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of etodolac enantiomers in the rat. Lack of pharmacokinetic interaction between enantiomers.
    Brocks DR; Jamali F
    Drug Metab Dispos; 1990; 18(4):471-5. PubMed ID: 1976070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of etodolac on articular and bone pathology associated with adjuvant arthritis in rats: a comparison with aspirin and naproxen.
    Martel RR; Klicius J; Metcalf G
    Agents Actions; 1984 Feb; 14(2):257-64. PubMed ID: 6231845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathologic evaluation of the effects of etodolac in established adjuvant arthritis in rats: evidence for reversal of joint damage.
    Weichman BM; Chau TT; Rona G
    Arthritis Rheum; 1987 Apr; 30(4):466-70. PubMed ID: 2953342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of long term treatment with etodolac, naproxen and ibuprofen on articular and bone changes associated with adjuvant arthritis in rats.
    Martel RR; Klicius J; Metcalf G; Rona GA
    Agents Actions; 1984 Oct; 15(3-4):403-12. PubMed ID: 6240930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective gas chromatographic analysis of etodolac enantiomers in human plasma and urine.
    Singh NN; Jamali F; Pasutto FM; Coutts RT; Russell AS
    J Chromatogr; 1986 Oct; 382():331-7. PubMed ID: 2946709
    [No Abstract]   [Full Text] [Related]  

  • 10. Disposition of etodolac, other anti-inflammatory pyranoindole-1-acetic acids and furobufen in normal and adjuvant arthritic rats.
    Ferdinandi ES; Cayen MN; Pace-Asciak C
    J Pharmacol Exp Ther; 1982 Feb; 220(2):417-26. PubMed ID: 6460096
    [No Abstract]   [Full Text] [Related]  

  • 11. Preparative resolution of etodolac enantiomers by preferential crystallization method.
    Dung PT; Trung TQ; Kim KH
    Arch Pharm Res; 2009 Oct; 32(10):1425-31. PubMed ID: 19898806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a stereospecific high-performance liquid chromatography assay to a pharmacokinetic study of etodolac enantiomers in humans.
    Jamali F; Mehvar R; Lemko C; Eradiri O
    J Pharm Sci; 1988 Nov; 77(11):963-6. PubMed ID: 2976091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal relationships of the anti-inflammatory effect of etodolac in the adjuvant arthritic rat.
    Lee DK; Chau TT; Weichman BM; Wooley PH
    Proc Soc Exp Biol Med; 1988 Mar; 187(3):273-7. PubMed ID: 2964641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antiinflammatory profile of (5H-dibenzo[a,d]-cyclohepten-5-ylidene)acetic acid (WY-41,770), an agent possessing weak prostaglandin synthetase inhibitory activity that is devoid of gastric side effects.
    Carlson RP; Datko LJ; Chang J; Nielsen ST; Lewis AJ
    Agents Actions; 1984 Jun; 14(5-6):654-61. PubMed ID: 6433676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological properties of the new non-steroidal anti-inflammatory agent etodolac.
    Inoue K; Fujisawa H; Sasaki Y; Nishimura T; Nishimura I; Inoue Y; Yokota M; Masuda T; Ueda F; Shibata Y
    Arzneimittelforschung; 1991 Mar; 41(3):228-35. PubMed ID: 1651085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison in rats of the anti-inflammatory and gastric irritant effects of etodolac with several clinically effective anti-inflammatory drugs.
    Martel RR; Klicius J
    Agents Actions; 1982 Jul; 12(3):295-7. PubMed ID: 6215841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats.
    Tachibana M; Inoue N; Yoshida E; Matsui M; Ukai Y; Yano J
    Pharmacology; 2003 Jun; 68(2):96-104. PubMed ID: 12711837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of prostaglandin biosynthesis by etodolac. I. Selective activities in arthritis.
    Neuman RG; Wilson BD; Barkley M; Kimball ES; Weichman BM; Wood DD
    Agents Actions; 1987 Jun; 21(1-2):160-6. PubMed ID: 2957897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The enantiomers of etodolac, a racemic anti-inflammatory agent, play different roles in efficacy and gastrointestinal safety.
    Inoue N; Nogawa M; Ito S; Tajima K; Kume S; Kyoi T
    Biol Pharm Bull; 2011; 34(5):655-9. PubMed ID: 21532152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of the antiinflammatory activity of fentiazac and its major metabolite, p-hydroxy fentiazac.
    Chang J; Carlson RP; Lewis AJ
    Agents Actions; 1984 Oct; 15(3-4):443-7. PubMed ID: 6441470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.